Pyruvate dehydrogenase deficiency and epilepsy

Brain and Development

Volumn 33, Issue 10, 2011, Pages 856-865

  Prasad, Chitra ^a,b   Rupar, Tony ^a,b   Prasad, Asuri N ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Autosomal recessive; Epilepsy; Lactic acidosis; Pyruvate dehydrogenase; X linked

Indexed keywords

ACETYL COENZYME A; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE COMPLEX;

BRAIN DEVELOPMENT; BRAIN MALFORMATION; DISEASE SEVERITY; EPILEPSY; EPILEPTOGENESIS; GENETIC COUNSELING; HUMAN; KETOGENIC DIET; LACTIC ACIDOSIS; PHENOTYPE; PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY; PYRUVATE DEHYDROGENASE COMPLEX E1 ALPHA POLYPEPTIDE DEFICIENCY; PYRUVATE DEHYDROGENASE COMPLEX E1 BETA POLYPEPTIDE DEFICIENCY; REVIEW; X CHROMOSOME INACTIVATION;

CHILD; EPILEPSY; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC NETWORKS AND PATHWAYS; PYRUVATE DEHYDROGENASE COMPLEX; PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY DISEASE;

EID: 80755140552     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2011.08.003     Document Type: Review

References (42)

1. Robinson B.H., Sherwood W.G. Lactic acidaemia. J Inherit Metab Dis 1984, 7(Suppl. 1):69-73.
2. Barnerias C., Saudubray J.M., Touati G., De Lonlay P., Dulac O., Ponsot G., et al. Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis. Dev Med Child Neurol 2010, 52:e1-e9.
3. Fujii T., Garcia Alvarez M.B., Sheu K.F., Kranz-Eble P.J., De Vivo D.C. Pyruvate dehydrogenase deficiency: the relation of the E1 alpha mutation to the E1 beta subunit deficiency. Pediatr Neurol 1996, 14:328-334.
4. Okajima K., Korotchkina L.G., Prasad C., Rupar T., Phillips J.A., Ficicioglu C., et al. Mutations of the E1 beta subunit gene (PDHB) in four families with pyruvate dehydrogenase deficiency. Mol Genet Metab 2008, 93:371-380.
5. Hiromasa Y., Fujisawa T., Aso Y., Roche T.E. Organization of the cores of the mammalian pyruvate dehydrogenase complex formed by E2 and E2 plus the E3-binding protein and their capacities to bind the E1 and E3 components. J Biol Chem 2004, 279:6921-6933.
6. Roche T.E., Baker J.C., Yan X., Hiromasa Y., Gong X., Peng T., et al. Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms. Prog Nucleic Acid Res Mol Biol 2001, 70:33-75.
7. Chun K., MacKay N., Petrova-Benedict R., Federico A., Fois A., Cole D.E., et al. Mutations in the X-linked E1 alpha subunit of pyruvate dehydrogenase: exon skipping, insertion of duplicate sequence, and missense mutations leading to the deficiency of the pyruvate dehydrogenase complex. Am J Hum Genet 1995, 56:558-569.
8. Quintana E., Gort L., Busquets C., Navarro-Sastre A., Lissens W., Moliner S., et al. Mutational study in the PDHA1 gene of 40 patients suspected of pyruvate dehydrogenase complex deficiency. Clin Genet 2010, 77:474-482.
9. Tripatara A., Kerr D.S., Lusk M.M., Kolli M., Tan J., Patel M.S. Three new mutations of the pyruvate dehydrogenase alpha subunit: a point mutation (M181V), 3 bp deletion (-R282), and 16 bp insertion/frameshift (K358SVS TVDQS). Hum Mutat 1996, 8:180-182.
10. Cameron J.M., Maj M., Levandovskiy V., Barnett C.P., Blaser S., Mackay N., et al. Pyruvate dehydrogenase phosphatase 1 (PDP1) null mutation produces a lethal infantile phenotype. Hum Genet 2009, 125:319-326.
11. Maj M.C., MacKay N., Levandovskiy V., Addis J., Baumgartner E.R., Baumgartner M.R., et al. Pyruvate dehydrogenase phosphatase deficiency: identification of the first mutation in two brothers and restoration of activity by protein complementation. J Clin Endocrinol Metab 2005, 90:4101-4107.
12. Robinson B.H., Sherwood W.G. Pyruvate dehydrogenase phosphatase deficiency: a cause of congenital chronic lactic acidosis in infancy. Pediatr Res 1975, 9:935-939.
13. Briones P., Lopez M.J., De Meirleir L., Ribes A., Rodes M., Martinez-Costa C., et al. Leigh syndrome due to pyruvate dehydrogenase E1 alpha deficiency (point mutation R263G) in a Spanish boy. J Inherit Metab Dis 1996, 19:795-796.
14. Robinson B.H., MacMillan H., Petrova-Benedict R., Sherwood W.G. Variable clinical presentation in patients with defective E1 component of pyruvate dehydrogenase complex. J Pediatr 1987, 111:525-533.
15. Makino M., Horai S., Goto Y., Nonaka I. Mitochondrial DNA mutations in Leigh syndrome and their phylogenetic implications. J Hum Genet 2000, 45:69-75.
16. Lee Y.M., Kang H.C., Lee J.S., Kim S.H., Kim E.Y., Lee S.K., et al. Mitochondrial respiratory chain defects: underlying etiology in various epileptic conditions. Epilepsia 2008, 49:685-690.
17. Prasad A.N., Bunzeluk K., Prasad C., Chodirker B.N., Magnus K.G., Greenberg C.R. Agenesis of the corpus callosum and cerebral anomalies in inborn errors of metabolism. Congenit Anom (Kyoto) 2007, 47:125-135.
18. Brown G.K., Otero L.J., LeGris M., Brown R.M. Pyruvate dehydrogenase deficiency. J Med Genet 1994, 31:875-879.
19. Nissenkorn A., Michelson M., Ben-Zeev B., Lerman-Sagie T. Inborn errors of metabolism: a cause of abnormal brain development. Neurology 2001, 56:1265-1272.
20. Chow C.W., Thorburn D.R. Morphological correlates of mitochondrial dysfunction in children. Hum Reprod 2000, 15(Suppl. 2):68-78.
21. Chow C.W., Anderson R.M., Kenny G.C. Neuropathology in cerebral lactic acidosis. Acta Neuropathol 1987, 74:393-396.
22. Canafoglia L., Franceschetti S., Antozzi C., Carrara F., Farina L., Granata T., et al. Epileptic phenotypes associated with mitochondrial disorders. Neurology 2001, 56:1340-1346.
23. Waldbaum S., Patel M. Mitochondrial dysfunction and oxidative stress: a contributing link to acquired epilepsy?. J Bioenerg Biomembr 2010, 42:449-455.
24. Chen S.D., Chang A.Y., Chuang Y.C. The potential role of mitochondrial dysfunction in seizure-associated cell death in the hippocampus and epileptogenesis. J Bioenerg Biomembr 2010, 42:461-465.
25. Pan J.W., Williamson A., Cavus I., Hetherington H.P., Zaveri H., Petroff O.A., et al. Neurometabolism in human epilepsy. Epilepsia 2008, 49(Suppl. 3):31-41.
26. Schousboe A., Westergaard N., Sonnewald U., Petersen S.B., Yu A.C., Hertz L. Regulatory role of astrocytes for neuronal biosynthesis and homeostasis of glutamate and GABA. Prog Brain Res 1992, 94:199-211.
27. Serres S., Raffard G., Franconi J.M., Merle M. Close coupling between astrocytic and neuronal metabolisms to fulfill anaplerotic and energy needs in the rat brain. J Cereb Blood Flow Metab 2008, 28:712-724.
28. Sibson N.R., Mason G.F., Shen J., Cline G.W., Herskovits A.Z., Wall J.E., et al. In vivo (13)C NMR measurement of neurotransmitter glutamate cycling, anaplerosis and TCA cycle flux in rat brain during [2-(13)C]glucose or [5-(13)C]glucose infusion. J Neurochem 2001, 76:975-989.
29. Klivenyi P., Starkov A.A., Calingasan N.Y., Gardian G., Browne S.E., Yang L., et al. Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity. J Neurochem 2004, 88:1352-1360.
30. Martin E., Rosenthal R.E., Fiskum G. Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress. J Neurosci Res 2005, 79:240-247.
31. Celsi F., Pizzo P., Brini M., Leo S., Fotino C., Pinton P., et al. Mitochondria, calcium and cell death: a deadly triad in neurodegeneration. Biochim Biophys Acta 2009, 1787:335-344.
32. Brini M. Ca(2+) signalling in mitochondria: mechanism and role in physiology and pathology. Cell Calcium 2003, 34:399-405.
33. Brini M., Pinton P., King M.P., Davidson M., Schon E.A., Rizzuto R. A calcium signaling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency. Nat Med 1999, 5:951-954.
34. Wexler I.D., Hemalatha S.G., McConnell J., Buist N.R., Dahl H.H., Berry S.A., et al. Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations. Neurology 1997, 49:1655-1661.
35. Naito E., Ito M., Yokota I., Saijo T., Chen S., Maehara M., et al. Concomitant administration of sodium dichloroacetate and thiamine in west syndrome caused by thiamine-responsive pyruvate dehydrogenase complex deficiency. J Neurol Sci 1999, 171:56-59.
36. Stacpoole P.W., Gilbert L.R., Neiberger R.E., Carney P.R., Valenstein E., Theriaque D.W., et al. Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate. Pediatrics 2008, 121:e1223-e1228.
37. Willemsen M., Rodenburg R.J., Teszas A., van den Heuvel L., Kosztolanyi G., Morava E. Females with PDHA1 gene mutations: a diagnostic challenge. Mitochondrion 2006, 6:155-159.
38. Naito E., Ito M., Yokota I., Saijo T., Ogawa Y., Shinahara K., et al. Gender-specific occurrence of West syndrome in patients with pyruvate dehydrogenase complex deficiency. Neuropediatrics 2001, 32:295-298.
39. Taylor M.R., Hurley J.B., Van Epps H.A., Brockerhoff S.E. A zebrafish model for pyruvate dehydrogenase deficiency: rescue of neurological dysfunction and embryonic lethality using a ketogenic diet. Proc Natl Acad Sci USA 2004, 101:4584-4589.
40. Owen Rt., Mandel R.J., Ammini C.V., Conlon T.J., Kerr D.S., Stacpoole P.W., et al. Gene therapy for pyruvate dehydrogenase E1alpha deficiency using recombinant adeno-associated virus 2 (rAAV2) vectors. Mol Ther 2002, 6:394-399.
41. Kang H.C., Kwon J.W., Lee Y.M., Kim H.D., Lee H.J., Hahn S.H. Nonspecific mitochondrial disease with epilepsy in children: diagnostic approaches and epileptic phenotypes. Childs Nerv Syst 2007, 23:1301-1307.
42. Wada N., Matsuishi T., Nonaka M., Naito E., Yoshino M. Pyruvate dehydrogenase E1alpha subunit deficiency in a female patient: evidence of antenatal origin of brain damage and possible etiology of infantile spasms. Brain Dev 2004, 26:57-60.